We also assessed PD-L1 expression levels in tumor tissues from three ovarian cancer patients before and after PARPi treatment and detected a significant increase in the intracellular accumulation of PD-L1, with minimal to no increase in cell membrane expression (Figure 1B). The gene discussed is CD274; the disease is ovarian cancer.